Savara (SVRA) Capital Leases (2015 - 2018)

Savara (SVRA) posted quarterly Capital Leases of $297000.0 for Q1 2018, up 2021.43% year-over-year from $14000.0 in Q1 2017, and little changed quarter-over-quarter from $297000.0 in Q4 2017.

Savara (SVRA) Capital Leases (2015 - 2018) Analysis & Trends

Savara (SVRA) has reported Capital Leases for 4 consecutive years, with $297000.0 the latest figure, recorded in Q1 2018.

  • In Q1 2018, Capital Leases rose 2021.43% year-over-year to $297000.0; the TTM figure through Mar 2018 stood at $297000.0 (up 2021.43% YoY), while the FY2017 annual figure was $297000.0, down 48.7% from the prior year.
  • Capital Leases held at $297000.0 in Q1 2018 per SVRA's latest filing, from $297000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $579000.0 in Q4 2016 and bottomed at $14000.0 in Q1 2017.
  • Historically, Capital Leases has averaged $172181.8 across 4 years, with a median of $25000.0 in 2015.
  • Annual changes were most pronounced in 2016 — Capital Leases soared 2216.0% — and 2017, when it tumbled 48.7%.
  • Savara's Capital Leases stood at $25000.0 in 2015, then jumped by 2216.0% to $579000.0 in 2016, then sank by 48.7% to $297000.0 in 2017, then changed by 0.0% to $297000.0 in 2018.
  • Business Quant data shows SVRA's Capital Leases at $297000.0 in Q1 2018, $297000.0 in Q4 2017, and $297000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Savara 1.11 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2018 297,000.00
Dec 31, 2017 297,000.00
Sep 30, 2017 297,000.00
Jun 30, 2017 297,000.00
Mar 31, 2017 14,000.00
Dec 31, 2016 579,000.00
Sep 30, 2016 19,000.00
Jun 30, 2016 21,000.00
Mar 31, 2016 24,000.00
Dec 31, 2015 25,000.00
Sep 30, 2015 24,000.00